Besunyen Holdings Company Limited (HKG:0926)
Hong Kong · Delayed Price · Currency is HKD | Market Cap | 303.22M +19.8% |
| Revenue (ttm) | 550.09M +2.1% |
| Net Income | 22.75M +38.1% |
| EPS | 0.19 +41.7% |
| Shares Out | 122.27M |
| PE Ratio | 13.33 |
| Forward PE | n/a |
| Dividend | 1.00 (40.65%) |
| Ex-Dividend Date | n/a |
| Volume | 3,075 |
| Average Volume | 3,264 |
| Open | 2.490 |
| Previous Close | 2.460 |
| Day's Range | 2.440 - 2.490 |
| 52-Week Range | 1.954 - 3.420 |
| Beta | 1.36 |
| RSI | 46.88 |
| Earnings Date | Mar 20, 2026 |
About Besunyen Holdings Company
Besunyen Holdings Company Limited, together with its subsidiaries, engages in the research and development, production, promotion, and sale of therapeutic tea products in the People’s Republic of China and internationally. The company operates through Tea Products; and Weight-Loss and Other Medicines segments. It offers therapeutic tea products, including Besunyen Detox Tea and Besunyen Slimming Tea; functional teas, such as Besunyen Fit Tea and Besunyen Relief Tea; and other tea products. The company provides over the counter (OTC) medicines c... [Read more]
Financial Performance
In 2025, Besunyen Holdings Company's revenue was 494.32 million, an increase of 2.07% compared to the previous year's 484.30 million. Earnings were 20.44 million, an increase of 38.09%.
Financial numbers in CNY Financial StatementsNews
Dietary Drugs Restore Besunyen's Fiscal Health In H1-25
Once a household name known for its ‘slimming tea,' the company is looking for a new formula in dietary drugs after years of losses and asset sales Key Takeaways: Besunyen logged a net profit of 12.4 ...